Jury Awards Transvaginal Mesh Patient $2M, Finding that C.R. Bard Failed to Warn of the Dangers of Its Avaulta Pelvic Mesh Device, Notes Parker Waichman LLP

Share Article

A federal jury reached a $2 million judgment against medical device manufacturer C.R. Bard over its Avaulta pelvic mesh device on Thursday, notes Parker Waichman LLP, which represents Plaintiffs who allege these products are defective and can cause grave injury.

News Image
With this verdict, the jury validates the Plaintiff’s claims. And since the allegations in this trial are similar to what many women in these litigations are saying, the verdict could serve as a sign of what is to come.

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that, according to court documents, a federal jury has awarded a total of $2 million in damages to a Georgia woman on Thursday, Aug. 15, 2013, after finding that C.R. Bard Inc. had failed to warn of the potential dangers associated with its Avaulta-branded vaginal mesh devices. The jurors awarded the woman $250,000 in compensatory damages and $1.75 million in punitive damages. The trial began on July 29, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195), with the Plaintiff contending that a transvaginal mesh device inserted inside her in 2009 had caused pelvic and rectal pain, bleeding and bladder spasms, and required multiple revision surgeries to remove it, according to court records.

“With this verdict, the jury validates the Plaintiff’s claims,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “And since the allegations in this trial are similar to what many women in these litigations are saying, the verdict could serve as a sign of what is to come.”

Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.

The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:

  •     Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)
  •     Pain
  •     Infection
  •     Bleeding
  •     Pain during sexual intercourse (dyspareunia)
  •     Organ perforation
  •     Urinary problems

The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP).

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
@ParkerWaichman
since: 09/2010
Follow >
Parker Waichman LLP

Follow us on
Visit website